|
gptkbp:instanceOf
|
Cannabis
|
|
gptkbp:actsOn
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:boilingPoint
|
155–157°C (at 0.05 mmHg)
|
|
gptkbp:broadcastOn
|
gptkb:Class_B_(UK)
gptkb:Schedule_II_(Canada)
gptkb:Schedule_I_(US_federal_law)
|
|
gptkbp:CASNumber
|
1972-08-3
|
|
gptkbp:category
|
recreational drug
metabolite
phytocannabinoid
terpenophenol
|
|
gptkbp:chemicalClass
|
gptkb:tetrahydrocannabinol
|
|
gptkbp:discoveredBy
|
gptkb:Raphael_Mechoulam
|
|
gptkbp:discoveredIn
|
1964
|
|
gptkbp:effect
|
anxiety
euphoria
altered perception
dry mouth
analgesia
impaired memory
increased appetite
|
|
gptkbp:eliminationHalfLife
|
1.6–59 hours
|
|
gptkbp:foundIn
|
Cannabis
|
|
gptkbp:hasApprovedDrug
|
gptkb:dronabinol
gptkb:nabilone
|
|
gptkbp:hasInChIKey
|
YXFVVABEGXRONW-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C21H30O2
|
|
gptkbp:hasSMILES
|
CC1=CC(=C2C(=C1)OC(C3=C2C=CC(=C3)C(C)(C)O)C)C
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
THC
|
|
gptkbp:IUPACName
|
gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
|
|
gptkbp:legalStatus
|
varies by country
|
|
gptkbp:medicalUse
|
analgesic
antiemetic
appetite stimulant
muscle relaxant
treatment of chronic pain
treatment of nausea
treatment of spasticity
|
|
gptkbp:meltingPoint
|
157°C
|
|
gptkbp:metabolism
|
gptkb:11-hydroxy-THC
gptkb:THC-COOH
liver
|
|
gptkbp:molecularWeight
|
314.464 g/mol
|
|
gptkbp:presentIn
|
gptkb:cannabis_oil
gptkb:hashish
marijuana
|
|
gptkbp:psychoactive
|
true
|
|
gptkbp:PubChem_CID
|
gptkb:CHEBI:66953
gptkb:ChEMBL651
gptkb:DB00470
16078
|
|
gptkbp:relatedTo
|
gptkb:Δ8-THC
gptkb:11-hydroxy-THC
gptkb:THCV
gptkb:CBD
gptkb:CBN
|
|
gptkbp:routeOfAdministration
|
oral
topical
inhalation
sublingual
|
|
gptkbp:solubility
|
insoluble in water
soluble in lipids
|
|
gptkbp:UNII
|
7J8887I17E
|
|
gptkbp:bfsParent
|
gptkb:Bitch,_Don't_Kill_My_Vibe
gptkb:Tenet_Healthcare
gptkb:Blank_Face_LP
gptkb:CBD
|
|
gptkbp:bfsLayer
|
5
|